A
Alessandro Leonildi
Researcher at University of Pisa
Publications - 61
Citations - 1645
Alessandro Leonildi is an academic researcher from University of Pisa. The author has contributed to research in topics: Colistin & Klebsiella pneumoniae. The author has an hindex of 18, co-authored 52 publications receiving 1062 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales
Marco Falcone,George L. Daikos,Giusy Tiseo,Dimitrios Bassoulis,Cesira Giordano,Valentina Galfo,Alessandro Leonildi,Enrico Tagliaferri,Simona Barnini,S. Sani,Alessio Farcomeni,Lorenzo Ghiadoni,Francesco Menichetti +12 more
TL;DR: CAZ-AVI/ATM combination offers therapeutic advantage compared to OAAs for patients with BSI due to MBLs-producing Enterobacterales, and a matched analysis confirmed these findings.
Journal ArticleDOI
Microbiology of cardiac implantable electronic device infections.
Maria Grazia Bongiorni,Carlo Tascini,Enrico Tagliaferri,Andrea Di Cori,Ezio Soldati,Alessandro Leonildi,Giulio Zucchelli,Ilaria Ciullo,Francesco Menichetti +8 more
TL;DR: Cardiac implantable electronic device infection is more often monomicrobial, CoNS are most frequently isolated and S. aureus is largely the main single agent, although oxacillin resistance and quinolones resistance has increased in the last 5 years.
Journal ArticleDOI
Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae
Carlo Tascini,Enrico Tagliaferri,Tommaso Giani,Alessandro Leonildi,Sarah Flammini,Beatrice Casini,Russell E. Lewis,S. Ferranti,Gian Maria Rossolini,Gian Maria Rossolini,Francesco Menichetti +10 more
TL;DR: Colistin-rifampin combinations may have a role in the treatment of multidrug-resistant K. pneumoniae and may possibly slow the selection of heteroresistant subpopulations during colistin therapy.
Journal ArticleDOI
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Marco Falcone,Matteo Bassetti,Giusy Tiseo,Cesira Giordano,Elia Nencini,Alessandro Russo,Elena Graziano,Enrico Tagliaferri,Alessandro Leonildi,Simona Barnini,Alessio Farcomeni,Francesco Menichetti +11 more
TL;DR: Time to appropriate antibiotic therapy is an independent predictor of 30-day mortality in patients with KPC-Kp BSI and receipt of an in vitro active therapy within 24 h from BC collection was associated with lower 30- day mortality.
Journal ArticleDOI
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
Marco Falcone,Giusy Tiseo,Cesira Giordano,Alessandro Leonildi,Melissa Menichini,Alessandra Vecchione,Mauro Pistello,Fabio Guarracino,Lorenzo Ghiadoni,Francesco Forfori,Simona Barnini,Francesco Menichetti +11 more
TL;DR: In this paper, the authors identify predictors of superinfections in COVID-19 patients, defined as a bacterial or fungal infection that occurred ≥48 h after hospital admission.